Serial angioscopic evaluation of neointimal coverage and incidence of thrombus formation after paclitaxel-eluting stent implantation: Comparison between 6- and 18-month follow-up

Clinical Cardiology

Volumn 34, Issue 5, 2011, Pages 322-326

  Hara, Masahiko ^a   Nishino, Masami ^a   Taniike, Masayuki ^a   Makino, Nobuhiko ^a   Kato, Hiroyasu ^a   Egami, Yasuyuki ^a   Shutta, Ryu ^a   Tanouchi, Jun ^a   Yamada, Yoshio ^a  

^a OSAKA ROSAI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOSCOPY; ARTICLE; CLINICAL ARTICLE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; MALE; NEOINTIMA; RETROSPECTIVE STUDY; STABLE ANGINA PECTORIS; STENT THROMBOSIS; TREATMENT OUTCOME;

AGED; ANGIOSCOPY; CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; FEMALE; HEALTH STATUS INDICATORS; HUMANS; INCIDENCE; MALE; NEOINTIMA; PACLITAXEL; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79955880439     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20881     Document Type: Article

References (18)

1. Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet. 2007; 370: 937-948. (Pubitemid 47393576)
2. Marroquin OC, Selzer F, Mulukutla SR, et al. A comparison of bare-metal and drug-eluting stents for off-label indications. N Engl J Med. 2008; 358: 342-352. (Pubitemid 351159233)
3. Costa MA, Simon DI., Molecular basis of restenosis and drug-eluting stents. Circulation. 2005; 111: 2257-2273. (Pubitemid 40632443)
4. Aoki J, Colombo A, Dudek D, et al. TAXUS II Study Group. Persistent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study. Circulation. 2005; 112: 3876-3883. (Pubitemid 43739485)
5. Hara M, Nishino M, Taniike M, et al. Difference of neointimal formational pattern and incidence of thrombus formation among 3 kinds of stents: an angioscopic study. JACC Cardiovasc Interv. 2010; 3: 215-220.
6. Hara M, Nishino M, Taniike M, et al. High incidence of thrombus formation at 18 months after paclitaxel-eluting stent implantation: angioscopic comparison with sirolimus-eluting stent. Am Heart J. 2010; 159: 905-910.
7. Asakura M, Ueda Y, Nanto S, et al. Remodeling of in-stent neointima, which became thinner and transparent over 3 years: serial angiographic and angioscopic follow-up. Circulation. 1998; 97: 2003-2006. (Pubitemid 28243660)
8. Kimura T, Yokoi H, Nakagawa Y, et al. Three-year follow-up after implantation of metallic coronary-artery stents. N Engl J Med. 1996; 334: 561-566. (Pubitemid 26066129)
9. Awata M, Kotani J, Uematsu M, et al. Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents. Circulation. 2007; 116: 910-916. (Pubitemid 47300915)
10. Degertekin M, Serruys PW, Foley DP, et al. Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up. Circulation. 2002; 106: 1610-1613.
11. Schatz RA, Palmaz JC, Tio FO, et al. Balloon-expandable intracoronary stents in the adult dog. Circulation. 1987; 76: 450-457. (Pubitemid 17127016)
12. Isner JM, Kearney M, Bortman S, et al. Apoptosis in human atherosclerosis and restenosis. Circulation. 1995; 91: 2703-2711.
13. Takano M, Yamamoto M, Murakami D, et al. Lack of association between large angiographic late loss and low risk of in-stent thrombus: angioscopic comparison between paclitaxel-and sirolimus-eluting stents. Circ Cardiovasc Interv. 2008; 1: 20-27.
14. Komatsu R, Ueda M, Naruko T, et al. Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses. Circulation. 1998; 98: 224-233. (Pubitemid 28337613)
15. Finn AV, Joner M, Nakazawa G, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation. 2007; 115: 2435-2441. (Pubitemid 46717966)
16. Lüscher TF, Steffel J, Eberli FR, et al. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation. 2007; 115: 1051-1058. (Pubitemid 46328299)
17. Eisenstein EL, Anstrom KJ, Kong DF, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA. 2007; 297: 159-168. (Pubitemid 46089732)
18. Van Werkum JW, Heestermans AA, Zomer AC, et al. Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. J Am Coll Cardiol. 2009; 53: 1399-1409.